In this video, you can watch what the calibration experts from the world’s top pharmaceutical companies think about calibration challenges, future trends and other calibration related topics.
The 2023 Beamex Pharmaceutical User Forum created an environment for attendees to learn from the experiences and proposals of their peers in the industry.
Done properly, digitalization can unlock a whole host of benefits for pharmaceutical companies including greater efficiency, cost savings, and the ability to do data analysis.
Major players in the pharmaceutical industry are embracing digitalization in their operations – the calibration processes, however, are still largely paper based.
This Calibration Essentials Software eBook contains 67 pages of guidance and insights into how calibration software can assist you in implementing best practices.
Many players in the pharma industry are making investments in digital solutions in order to enhance their calibration processes. But how can you make sure these investments pay off?
For pharmaceutical companies, the compliance to regulation is naturally a vital consideration. There is a strive to remove paper-based systems for recording and approval in calibration solutions and to digitalize the whole calibration process.
For pharmaceutical companies, the compliance to regulation is naturally a vital consideration. There is a strive to remove paper-based systems for recording and approval in calibration solutions and to digitalize the whole calibration process.
GlaxoSmithKline is one of the world’s leading research based pharmaceutical and healthcare companies with a share of approximately 5% of the world’s pharmaceutical market.
